Long-term safety and tolerability of tozorakimab in patients with COPD and history of exacerbations

Trial Identifier: D9180C00015
Sponsor: AstraZeneca
Collaborator:
Clinact, Multihealth Group
Contract Research Organization
Start Date: May 2026
Primary Completion Date: December 2028
Study Completion Date: December 2028
Condition: Chronic Obstructive Pulmonary Disease (COPD)

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
France Aix en Provence, France, 13100
France Brest, France, 29200
France Epagny Metz Tessy, France, 74370
France Grenoble cedex 9, France, 38043
France Lyon cedex 04, France, 69317
France Marseille, France, 13015
France Montpellier, France, 34090
France Pessac, France, 33600
France Quimper cedex, France, 29107
France Saint-Herblain, France, 44800
France Toulouse, France, 31400
France Villefranche sur Saone cedex, France, 69655